ArticleRadiation protection dosimetry2025
Impact of a patient fixation device on healthcare worker radiation doses in fluoroscopy-assisted endoscopy.
Article in Radiation protection dosimetry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsHealthcare professionals involved in fluoroscopy-guided endoscopy are occupationally exposed to ionizing radiation. We evaluated whether a patient-immobilization device, MEDO V-Fix®, reduces this exposure.
methodsMonthly effective and lens equivalent dose were measured for nurses and doctors using personal dosemeters worn inside protective gear. Data from 7 months before and 10 months after device introduction were compared. Additionally a cost-benefit analysis (CBA) of dose reduction was performed.
resultsMonthly effective doses fell in both professions, but neither decline reached statistical significance. By contrast, nurses' mean lens-equivalent dose dropped sharply from 35.0 to 6.5 μSv per procedure (P < 0.01), whereas the reduction in doctors was not significant. In the CBA, assuming a 5-y service life, the benefit-to-cost ratio ranged 1.02-2.72, indicating economic merit.
conclusionsThe MEDO V-Fix significantly reduces the occupational radiation exposure of endoscopy nurses and is a worthwhile investment from a CBA perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.